Mark W Zimmerman

Mark W Zimmerman

Harvard University - Cambridge / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 1346065
person_outline Mark W Zimmerman's MOST POPULAR ARTICLES
1-) Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitryAD Durbin, MW Zimmerman, NV Dharia, BJ Abraham, AB Iniguez, ...Nature genetics 50 (9), 1240-1246, 20181462018
2-) MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer AmplificationMW Zimmerman, Y Liu, S He, AD Durbin, BJ Abraham, J Easton, Y Shao, ...Cancer discovery 8 (3), 320-335, 20181382018
3-) Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivoC Dubiella, BJ Pinch, K Koikawa, D Zaidman, E Poon, TD Manz, B Nabet, ...Nature chemical biology 17 (9), 954-963, 2021942021
4-) LMO1 synergizes with MYCN to promote neuroblastoma initiation and metastasisS Zhu, X Zhang, N Weichert-Leahey, Z Dong, C Zhang, G Lopez, T Tao, ...Cancer cell 32 (3), 310-323. e5, 2017992017
5-) Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancerMW Zimmerman, GE Homanics, JS LazoPloS one 8 (3), e58300, 2013852013